A Call to FDA Leadership: Let's Modernize Clinical Trials to Finally Tackle Cancer Prevention
Our shared goal is to reduce the burden of cancer. While treatment has advanced, true victory lies in prevention. In the crucial arena of primary prevention for high-risk individuals and prevention of secondary cancers, our current clinical trial models are failing. We face a logistical and economic impasse that requires a strategic modernization of our…
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.